Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | DGKA | P23743 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | HTR1A | P08908 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL1527707 | 1.00 | ADRA2A (0.40) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Ethylene SCHEMBL9698670 | 1.00 | ADRA2A (0.40) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL243060 | 0.94 | ADRA2A (0.43) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Ammonia Solution, Strong SCHEMBL2580733 | 0.90 | ADRA2A (0.42) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL6683309 | 0.90 | ADRA2A (0.42) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Ethylene SCHEMBL3385945 | 0.88 | TSHR (0.48) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| Ethylene Glycol SCHEMBL10891322 | 0.88 | ADRA2A (0.40) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL3385884 | 0.85 | TSHR (0.44) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL15282788 | 0.82 | ADRA2A (0.37) | ADRA2AADRA1AMAPTBLMCYP2C19 | |
| SCHEMBL4292348 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092375-A1 | SUPRAMOLECULAR ORGANOMETALLIC CURABLE FLUIDS TO COAT SUBSTRATES WITH METAL CARBIDES | WOLFSPEED INC (US) | 2026-04-02 | — | — | US | claimed |
| EP-1756353-B1 | ACID DONORS FOR DYEING POLYAMIDE | HUNTSMAN ADV MAT SWITZERLAND (CH) | 2010-12-01 | — | — | EP | claimed |
| US-7728067-B2 | Acid donors for dyeing polyamide | HUNTSMAN INTERNATIONAL LLC (US) | 2010-06-01 | — | — | US | claimed |
| US-20080271260-A1 | Acid Donors for Dyeing Polyamide | PETER HANS-JORG | 2008-11-06 | — | — | US | claimed |
| EP-1756353-A1 | ACID DONORS FOR DYEING POLYAMIDE | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2007-02-28 | — | — | EP | claimed |
| WO-2005106107-A1 | ACID DONORS FOR DYEING POLYAMIDE | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2005-11-10 | — | — | WO | claimed |
| US-6908692-B1 | Electrically conductive wire with curable coating including reactive particles based on element-oxygen network and binder which reacts with particle; cures to inorganic-organic-oxygen network with high partial discharge resistance | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-06-21 | — | — | US | claimed |
| US-6849822-B2 | Coating composition for metal conductors and coating process involving the use thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2005-02-01 | — | — | US | claimed |
| US-20040159634-A1 | Coating composition for metal conductors and coating process involving the use thereof | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-08-19 | — | — | US | claimed |
| EP-1166283-B1 | COATING COMPOSITION FOR METALLIC CONDUCTORS AND COATING METHOD USING SAME | DU PONT (US) | 2003-10-15 | — | — | EP | claimed |
| WO-2003057786-A1 | COATING COMPOSITION FOR METAL CONDUCTORS AND COATING PROCESS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-07-17 | — | — | WO | claimed |
| US-20030129396-A1 | Coating composition for metal conductors and coating process involving the use thereof | E.I. DU PONT DE NEMOURS AND COMPANY | 2003-07-10 | — | — | US | claimed |
| US-12629358-B2 | Compound used as RET kinase inhibitor and application thereof | TYK MEDICINES, INC. (CN) | 2026-05-19 | — | — | US | disclosed |
| EP-4727940-A1 | DIHYDROPYRIMIDINE-2, 4 (1H, 3H) -DIONE-CONTAINING POLYCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREOF AND USE THEREOF | Linkcure Therapeutics (KY) | 2026-04-22 | — | — | EP | disclosed |
| EP-4155304-B9 | COMPOUND USED AS RET KINASE INHIBITOR AND APPLICATION THEREOF | TYK MEDICINES INC (CN) | 2026-04-15 | — | — | EP | disclosed |
| US-20260092375-A1 | SUPRAMOLECULAR ORGANOMETALLIC CURABLE FLUIDS TO COAT SUBSTRATES WITH METAL CARBIDES | WOLFSPEED INC (US) | 2026-04-02 | — | — | US | disclosed |
| US-20030129396-A1 | Coating composition for metal conductors and coating process involving the use thereof | E.I. DU PONT DE NEMOURS AND COMPANY | 2003-07-10 | — | — | US | disclosed |
| US-6162890-A | Water-dispersible block copolyesters useful as low-odor adhesive raw materials | EASTMAN CHEMICAL COMPANY (US) | 2000-12-19 | — | — | US | disclosed |
| WO-1992005838-A1 | DICHLOROMETHANE ABATEMENT | EASTMAN KODAK COMPANY (US) | 1992-04-16 | — | — | WO | disclosed |
| US-5035809-A | Controlling water pollution | EASTMAN KODAK COMPANY (US) | 1991-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092375-A1 | SUPRAMOLECULAR ORGANOMETALLIC CURABLE FLUIDS TO COAT SUBSTRATES WITH METAL CARBIDES | SLIRP, CBL, SPIN1 | ADRA2A 4624/4885ADRA1A 4640/4885MAPT 644/4885 |
| US-12629358-B2 | Compound used as RET kinase inhibitor and application thereof | RET, ALK, FGFR3 | ADRA2A 1991/4885ADRA1A 1840/4885MAPT 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.